Bank Of America Corp Timber Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.28 - $0.41 $16 - $24	-59 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$0.38 - $0.89 $22 - $52	59 New	59 $0
Q3 2021 Nov 15, 2021	SELL	$0.89 - $1.18 $11 - $15	-13 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$1.06 - $2.25 $13 - $29	13 New	13 $0

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.